Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.

ABSTRACT: We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.

SUBMITTER: Yoshiyama T 

PROVIDER: S-EPMC7853542 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature